Stability and Transport Validation for the Belarus Market

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

What stability and transport validation must prove is that the product, from release to use, still meets its specifications under the storage and transport conditions declared on the label. The validation conditions must correspond to the label declarations item by item; a mismatch between the two is a common reason for requests for correction and one of the cheapest to prevent.

Transport conditions deserve the same seriousness as storage conditions, because damage during distribution is indistinguishable, in the user’s hands, from a product that never met its specification. A validation program that treats transport as part of the normal life of the product, with defined worst cases and acceptance criteria, produces a file that answers the questions of the reviewer before they are asked and protects the manufacturer later when a damaged batch must be explained.

2. Legal basis

RegulationNumber or identifierDate of publication or entry into forceKey provisions
Decision of the Council of the Eurasian Economic Commission on General Safety and Effectiveness Requirements, Labeling and Operating DocumentationNo. 272016-02-12Safety and effectiveness requirements and labeling requirements
On Preliminary Technical Work Prior to State RegistrationMinistry of Health No. 55 (amended by No. 120)2015-04-23Registration dossier document requirements
On State Registration (Re-registration) of Medical DevicesCouncil of Ministers No. 211 (6-1/55925)Effective 2026-05-01Registration procedure; closed list principle
Technical regulation of Belarus, Medical Devices. SafetyTR 2010/006/BYCurrentNational safety requirements

3. Expert insights

Insight one: transport validation must take account of the climate conditions of Belarus. Belarus has a temperate continental climate with pronounced winter cold. The temperature range that a product experiences during sea and land transport when exported, and the temperature range of the actual use environment, should both be covered by the validation, especially for products containing liquids, batteries or electronic components, where a single unconsidered freeze-thaw cycle can invalidate the whole claim.

Insight two: transport validation can combine actual shipments with simulated testing. For products that are bulky or inconvenient to simulate, a combination of monitored actual transport and partial simulated testing may be used, provided the protocol explains the rationale and the coverage of the chosen approach. The explanation matters because a mixed design without a stated rationale gives reviewers nothing to check the completeness against.

Insight three: stability data must support every declaration on the label. Each labeled declaration, storage temperature, humidity, light protection, expiry date and the rest, needs corresponding validation data. The more declarations there are, the heavier the validation burden; enterprises should therefore avoid unnecessary additional declarations when they design the label, because every extra sentence on the label is an extra study in the file.

Insight four: a packaging change triggers revalidation. After changing the packaging material or the transport mode, the conclusions of the original transport validation may no longer apply. Whether such a change requires a change to the registration dossier should be confirmed in writing with the local representative using the method described in article 18 of this series.

Insight five: the file should show the reasoning that connects the studies to the label, not only the raw reports. A short matrix listing each label declaration against the study that supports it gives the reviewer an immediate map of the evidence and exposes gaps before they become queries. The same matrix serves the manufacturer later, when a declaration is changed or a market extension is considered: the cells of the matrix show at once which studies are affected. Producing the matrix during validation planning, rather than after the reports exist, keeps the studies aligned with the label from the start.

4. Practical recommendations

  1. Fix the label declarations first, then validate. Design the validation protocol around the storage and transport conditions intended for the label, so that validation does not finish short of the declared claims.
  2. Cover the winter low-temperature range. For products destined for the Belarus market, the validated temperature range should include the actual winter temperatures.
  3. Reduce unnecessary label declarations. Every additional declaration adds a corresponding validation burden.
  4. Include packaging changes in the change assessment. After changing packaging material or transport mode, reassess both the validation conclusions and the notification obligations.

5. Verification checklist

  • □ Validation conditions correspond to the label declarations item by item
  • □ The temperature range covers the actual winter conditions of Belarus
  • □ Label declarations have been reduced to the necessary items
  • □ Packaging changes are included in the change assessment process
  • □ The validation reports satisfy the requirements of the annex to No. 55

Regulatory information verified as of October 30, 2026.

In the Eurasian Economic Union market, the core capabilities of GRZAN concentrate on three points. First, distinguishing between the two channels of Union-wide registration and national registration in each member state, including their applicable conditions and remaining time windows. The national registration procedure of Belarus has been fully restructured by Council of Ministers Resolution No. 211 of April 28, 2026 (state register number 6-1/55925, effective May 1, 2026), which compressed the total time limit for preliminary technical work to 90 calendar days, applied a closed list that the implementing organization is prohibited from expanding, while applications under the national procedure face the key deadline of December 31, 2027, so pathway selection must be decided in sync with the time window. Second, local authorized representative services, acting as the legal representative of the manufacturer in Belarus, handling registration submission, responses to technical queries, changes to the registration dossier, and post-market reporting obligations; GRZAN has updated its coordination mechanisms after Council of Ministers Resolution No. 378 of July 27, 2026 (effective July 30, 2026) transferred adverse event functions to the state institution Gosfarmnadzor. Third, quality system and testing support, assisting in establishing a quality management system compliant with ISO 13485 and organizing the technical documentation according to the target pathway: for the national pathway, the annex to Ministry of Health Resolution No. 55; for the Union pathway, Decision No. 46 of the Council of the Eurasian Economic Commission.

Business inquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail